Xphozah 30 Mg
Payments companies reported to CMS as associated with Xphozah 30 Mg. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Xphozah 30 Mg, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Xphozah 30 Mg
These are the largest totals companies reported as associated with Xphozah 30 Mg. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Nelson Kopyt | Allentown, PA | Nephrology (Internal Medicine) | $78,548.41 |
| Glenn Chertow | Stanford, CA | Nephrology (Internal Medicine) | $73,100.00 |
| Vincent Carsillo | Albany, NY | Nephrology (Internal Medicine) | $71,984.66 |
| Jose Morfin | Sacramento, CA | Nephrology (Internal Medicine) | $67,458.48 |
| Rodolfo Batarse | Rancho Mirage, CA | Nephrology (Internal Medicine) | $63,375.83 |
| Stuart Sprague | Evanston, IL | Nephrology (Internal Medicine) | $46,149.26 |
| Mohammed Ahmed | Bolingbrook, IL | Nephrology (Internal Medicine) | $40,597.21 |
| Wayne Kotzker | Fort Lauderdale, FL | Nephrology (Internal Medicine) | $39,662.10 |
| Kevin Martin | St Louis, MO | Nephrology (Internal Medicine) | $33,100.00 |
| Niloofar Nobakht | Los Angeles, CA | Nephrology (Internal Medicine) | $31,591.96 |
Prescribed Xphozah 30 Mg?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.